EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Repurposing a Small Molecule Plant Hormone as a Tunable ON‐Switch for CAR‐T Cell Immunotherapy

Hongxiang Zeng iD, Lei Zheng iD, Rongkun Tao iD, Sirui Zheng, Yanke Zhong, Yongxia Niu, Peng Zhang iD, Xiang Ma, Chen Yang, Min Zhang, Fuyu Duan, Jing Yang and 5 more

Advanced Science · 2026-11 · 13 (61)

DOI: 10.1002/advs.77020 ↗

At a glance

Journal article in Advanced Science, published online on 2026-08-11. Written by Hongxiang Zeng and 16 co-authors. Institution: Faculty of Synthetic Biology, and Institute of Cell and Gene Technology, Shenzhen University of Advanced Technology, Shenzhen, China. Major MEDLINE topics: Plant Growth Regulators, Receptors, Chimeric Antigen, Immunotherapy, Adoptive, T-Lymphocytes. 71 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Key Research and Development Program of China, Shenzhen-Hong Kong joint Science and Technology Innovation Program, National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Precise regulation of chimeric antigen receptor (CAR)‐T cell activity is essential to maximize efficacy and minimize toxicity. While switch‐controlled CAR‐T holds great promise, challenges remain in achieving accurate activation, reducing immunogenicity, and preventing off‐target effects. Here we present a novel inducible ON‐switch CAR design that leverages plant hormone signaling components to achieve controllable T cell activation. By engineering a receptor system integrating the plant auxin receptor AFB1 with its co‐receptor IAA7, we enable ligand‐dependent interactions triggered by the plant hormone auxins. This design allows rapid, reversible, and dose‐dependent T cell activation, resulting in potent cytotoxicity against B‐cell lymphoma in vitro and in vivo. Notably, auxCAR‐T cells controlled by synthetic auxin analogs maintain a favorable memory phenotype and exhibit reduced functional exhaustion during treatment, leading to improved therapeutic efficacy. Our plant hormone‐based orthogonal system overcomes key limitations of existing switch systems and advances the development of precision CAR‐T therapies.

Subjects

MeSH terms (MEDLINE)

Plant Growth RegulatorsReceptors, Chimeric AntigenImmunotherapy, AdoptiveT-LymphocytesHumansAnimalsIndoleacetic AcidsLymphocyte Activation

Author keywords

auxincell biologychimeric antigen receptorcytotoxicityhormoneimmunogenicityimmunotherapyplant hormonesmall moleculet cell

Substances

Plant Growth RegulatorsReceptors, Chimeric AntigenIndoleacetic Acids

Authors and institutions

  • Faculty of Synthetic Biology, and Institute of Cell and Gene Technology, Shenzhen University of Advanced Technology, Shenzhen, China.
  • State Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • Department of Chemistry, New York University, New York, USA.
  • New York University-East China Normal University Center for Computational Chemistry, School of Chemistry and Molecular Engineering, New York University Shanghai, Shanghai, China.
  • The First Affiliated Hospital of Xiamen University, School of Medicine, Clinical Research Institute, Xiamen University, Xiamen, China.
  • Institute of Emerging Agricultural Technology, Shenzhen University of Advanced Technology, Shenzhen, China.

ORCID profiles: Hongxiang Zeng, Lei Zheng, Rongkun Tao, Peng Zhang, Xiang Zhou, Zhaoxi Sun, Qizhou Lian

Funding

  • National Key Research and Development Program of China
  • Shenzhen-Hong Kong joint Science and Technology Innovation Program
  • National Natural Science Foundation of China
  • National Natural Science Foundation of China Grant
  • Shenzhen Science and Technology Program
  • Shenzhen Science and Technology Innovation Program

Cite

APA

Zeng, H., Zheng, L., Tao, R., Zheng, S., Zhong, Y., Niu, Y., Zhang, P., Ma, X., Yang, C., Zhang, M., Duan, F., Yang, J., Wei, X., Zhou, X., Yang, Z., Sun, Z., & Lian, Q. (2026). Repurposing a Small Molecule Plant Hormone as a Tunable ON‐Switch for CAR‐T Cell Immunotherapy. Advanced Science, 13(61). https://doi.org/10.1002/advs.77020

Vancouver

Zeng H, Zheng L, Tao R, Zheng S, Zhong Y, Niu Y, et al. Repurposing a Small Molecule Plant Hormone as a Tunable ON‐Switch for CAR‐T Cell Immunotherapy. Advanced Science. 2026;13(61). doi:10.1002/advs.77020

BibTeX
@article{Zeng2026,
  author = {Zeng, Hongxiang and Zheng, Lei and Tao, Rongkun and Zheng, Sirui and Zhong, Yanke and Niu, Yongxia and Zhang, Peng and Ma, Xiang and Yang, Chen and Zhang, Min and Duan, Fuyu and Yang, Jing and Wei, Xuan and Zhou, Xiang and Yang, Zhenbiao and Sun, Zhaoxi and Lian, Qizhou},
  title = {Repurposing a Small Molecule Plant Hormone as a Tunable ON‐Switch for CAR‐T Cell Immunotherapy},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {61},
  doi = {10.1002/advs.77020}
}
Start for free →